标题
The potential role of vitamin C in empowering cancer immunotherapy
作者
关键词
Vitamin C, Immune checkpoint blockade, Immunotherapy, Cancer therapy
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 146, Issue -, Pages 112553
出版商
Elsevier BV
发表日期
2021-12-20
DOI
10.1016/j.biopha.2021.112553
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model
- (2020) Rebecca A. Luchtel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-dose vitamin C enhances cancer immunotherapy
- (2020) Alessandro Magrì et al. Science Translational Medicine
- The function of miR-200 family in oxidative stress response evoked in cancer chemotherapy and radiotherapy
- (2020) Joanna Kozak et al. BIOMEDICINE & PHARMACOTHERAPY
- Regulation of PD-L1 expression on cancer cells with ROS-modulating drugs
- (2020) Christian Bailly LIFE SCIENCES
- Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
- (2020) Rikki A. M. Brown et al. Frontiers in Oncology
- Prognostic value of the miR-200 family in bladder cancer
- (2020) Yanhui Mei et al. MEDICINE
- Regulation of PD-L1 Expression by NF-κB in Cancer
- (2020) Fabrizio Antonangeli et al. Frontiers in Immunology
- Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer
- (2019) Ping Fan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells
- (2019) SOO JUNG LEE et al. ANTICANCER RESEARCH
- Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti‐PD‐L1 antibody for treatment of triple‐negative breast cancer
- (2019) PV Raninga et al. INTERNATIONAL JOURNAL OF CANCER
- Vitamin C promotes the proliferation and effector functions of human γδ T cells
- (2019) Léonce Kouakanou et al. Cellular & Molecular Immunology
- IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
- (2019) Li-Chuan Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
- (2019) Yan-ping Xu et al. JOURNAL OF CLINICAL INVESTIGATION
- HIF1α/PD-L1 axis mediates hypoxia-induced cell apoptosis and tumor progression in follicular thyroid carcinoma
- (2019) Lingyan Zhou et al. OncoTargets and Therapy
- Antipsychotic Drug Trifluoperazine Suppresses Colorectal Cancer by Inducing G0/G1 Arrest and Apoptosis
- (2019) Yong Xia et al. Frontiers in Pharmacology
- Reactive Oxygen Species in the Tumor Microenvironment: An Overview
- (2019) Frank Weinberg et al. Cancers
- Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
- (2019) Muhammad Zaeem Noman et al. Cells
- Combined blockade of IL-6 and PD-1/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment
- (2018) Hirotake Tsukamoto et al. CANCER RESEARCH
- Correlation between Programmed Death-1 Ligand-1 and p53 in Patients with Lung Adenocarcinoma
- (2018) Zhi-Hong Zhang et al. CHINESE MEDICAL JOURNAL
- Pharmacologic ascorbate (P-AscH−) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma
- (2018) Justin G. Wilkes et al. CLINICAL & EXPERIMENTAL METASTASIS
- Association of PD-L1 and HIF-1α Coexpression with Poor Prognosis in Hepatocellular Carcinoma
- (2018) Xiaomeng Dai et al. Translational Oncology
- Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression
- (2018) David W. Sant et al. Scientific Reports
- Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence
- (2018) Margreet C. M. Vissers et al. Frontiers in Physiology
- PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma
- (2018) A. Asgarova et al. OncoImmunology
- Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
- (2018) Anchalee Rawangkan et al. MOLECULES
- Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression
- (2018) Sungrae Cho et al. Scientific Reports
- Inhibitory Effect of Anoectochilus formosanus Extract on Hyperglycemia-Related PD-L1 Expression and Cancer Proliferation
- (2018) Yih Ho et al. Frontiers in Pharmacology
- Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
- (2018) Anitra C. Carr et al. Frontiers in Physiology
- Ascorbic Acid Chemosensitizes Colorectal Cancer Cells and Synergistically Inhibits Tumor Growth
- (2018) Ana S. Pires et al. Frontiers in Physiology
- Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
- (2017) Xun Wang et al. IMMUNOLOGY LETTERS
- Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma
- (2017) Steven C. Kao et al. Journal of Thoracic Oncology
- The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cells
- (2017) Kyoung Eun Lee et al. Oncology Letters
- Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
- (2017) N Shenoy et al. Blood Cancer Journal
- IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
- (2016) Thomas A Mace et al. GUT
- PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma
- (2016) Melanie Ruf et al. INTERNATIONAL JOURNAL OF CANCER
- Control of Foxp3 stability through modulation of TET activity
- (2016) Xiaojing Yue et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vitamin C Facilitates Demethylation of theFoxp3Enhancer in a Tet-Dependent Manner
- (2016) Varun Sasidharan Nair et al. JOURNAL OF IMMUNOLOGY
- Regulation of PD-L1: a novel role of pro-survival signalling in cancer
- (2015) J. Chen et al. ANNALS OF ONCOLOGY
- Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells
- (2015) Sarah L. Miles et al. BMC CANCER
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
- (2015) Xi Wang et al. CELLULAR SIGNALLING
- Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy
- (2015) Mirelle J.A.J. Huijskens et al. CYTOTHERAPY
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
- (2015) Qian Zhang et al. NATURE
- Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof
- (2015) Tseng-Cheng Chen et al. ORAL ONCOLOGY
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
- (2015) J. Yun et al. SCIENCE
- Epigenetic reprogramming of melanoma cells by vitamin C treatment
- (2015) Christopher B Gustafson et al. Clinical Epigenetics
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress
- (2015) Megumi Uetaki et al. Scientific Reports
- Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
- (2014) I. B. Barsoum et al. CANCER RESEARCH
- Vitamin C treatment of mouse bone marrow-derived dendritic cells enhanced CD8+ memory T cell production capacity of these cells in vivo
- (2014) Young-Joo Jeong et al. IMMUNOBIOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
- (2014) Y. Ma et al. Science Translational Medicine
- Epigenetic Impacts of Ascorbate on Human Metastatic Melanoma Cells
- (2014) Sascha Venturelli et al. Frontiers in Oncology
- Increased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal Cancer
- (2014) Caroline Kuiper et al. Frontiers in Oncology
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
- (2013) Christopher M. Stephenson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MiR-200, a new star miRNA in human cancer
- (2013) Xiangling Feng et al. CANCER LETTERS
- MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis
- (2013) B. Singh et al. CARCINOGENESIS
- Histone Acetyltransferase 1 Promotes Homologous Recombination in DNA Repair by Facilitating Histone Turnover
- (2013) Xiaohan Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High Concentrations of L-Ascorbic Acid Specifically Inhibit the Growth of Human Leukemic Cells via Downregulation of HIF-1α Transcription
- (2013) Hiroshi Kawada et al. PLoS One
- Tumour angiogenesis regulation by the miR-200 family
- (2013) Chad V. Pecot et al. Nature Communications
- Review of MiR-200b and cancer chemosensitivity
- (2012) Bing Feng et al. BIOMEDICINE & PHARMACOTHERAPY
- Enhanced antitumor activity of vitamin C via p53 in Cancer cells
- (2012) Jinsun Kim et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effect of high-dose intravenous vitamin C on inflammation in cancer patients
- (2012) Nina Mikirova et al. Journal of Translational Medicine
- SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment
- (2012) S-W Hong et al. ONCOGENE
- Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
- (2011) Kristine H. Allin et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
- (2010) Y Wu et al. BRITISH JOURNAL OF CANCER
- Low Ascorbate Levels Are Associated with Increased Hypoxia-Inducible Factor-1 Activity and an Aggressive Tumor Phenotype in Endometrial Cancer
- (2010) C. Kuiper et al. CANCER RESEARCH
- Vitamin C-treated murine bone marrow-derived dendritic cells preferentially drive naïve T cells into Th1 cells by increased IL-12 secretions
- (2010) Young-Joo Jeong et al. CELLULAR IMMUNOLOGY
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects
- (2010) Sebastian J. Padayatty et al. PLoS One
- Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
- (2010) Z. K. Pinnix et al. Science Translational Medicine
- Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
- (2009) Kristine H. Allin et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
- (2008) L. J. Hoffer et al. ANNALS OF ONCOLOGY
- Redox signaling and cancer: The role of “labile” iron
- (2008) Dimitrios Galaris et al. CANCER LETTERS
- Vitamin C treatment reduces elevated C-reactive protein
- (2008) G BLOCK et al. FREE RADICAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search